NEUP (Neuphoria Therapeutics) Float Percentage Of Total Shares Outstanding: 99.89% (As of Jun. 30, 2026)


NEUP Neuphoria Therapeutics Inc NEUP
32 GF Score
Price $4.37
! 1 Warning Sign
View Full Analysis

What is Neuphoria Therapeutics Float Percentage Of Total Shares Outstanding?

Neuphoria Therapeutics NEUP -0.68% 32 Float Percentage Of Total Shares Outstanding is 99.89% as of Jun. 30, 2026. GuruFocus rates NEUP with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Neuphoria Therapeutics's float shares is 5.39 Mil. Neuphoria Therapeutics's total shares outstanding is 5.40 Mil. Neuphoria Therapeutics's float percentage of total shares outstanding is 99.89%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Neuphoria Therapeutics's Insider Ownership is 0.19%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Neuphoria Therapeutics's Institutional Ownership is 33.08%.

NEUP
32GF Score
Neuphoria Therapeutics Inc NEUP
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuphoria Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Neuphoria Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.39/5.40
=99.89%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.89% mean?
Neuphoria Therapeutics (NEUP) has a Float Percentage Of Total Shares Outstanding of 99.89% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Neuphoria Therapeutics and its competitors.
Is Neuphoria Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Neuphoria Therapeutics' current Float Percentage Of Total Shares Outstanding is 99.89%. Overall, Neuphoria Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Neuphoria Therapeutics' Float Percentage Of Total Shares Outstanding compare to PLRZ and SKYE?
Neuphoria Therapeutics' Float Percentage Of Total Shares Outstanding of 99.89% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Neuphoria Therapeutics and its competitors. Neuphoria Therapeutics's current Float Percentage Of Total Shares Outstanding is 99.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuphoria Therapeutics stock overvalued right now?
Neuphoria Therapeutics (NEUP) has a current Float Percentage Of Total Shares Outstanding of 99.89%. The current Float Percentage Of Total Shares Outstanding is 99.89%. Neuphoria Therapeutics' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Neuphoria Therapeutics (NEUP), the current Float Percentage Of Total Shares Outstanding is 99.89% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neuphoria Therapeutics Business Description

Address 100 Summit Drive, Burlington, MA, USA, 01803
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
32GF Score

Get the complete analysis for NEUP

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.37
Price